Stocks Pfizer Inc

More

  • What Drove This Pharma's Heavy Options Activity? Monday, 27 Jul 2009 | 8:18 AM ET

    Shares of Acadia Pharmaceuticals skyrocketed along with heavy options activity at the end of last week.

  • Your First Move For Monday July 27th Friday, 24 Jul 2009 | 6:07 PM ET

    Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!

  • Dow Has Strongest Two Weeks Since 2000 Friday, 24 Jul 2009 | 5:12 PM ET

    The latest batch of earnings took a toll on the market Friday but the Dow still pulled off a gain in the final half hour of trading, capping its best two-week performance since 2000. Microsoft shares fell more than 8%.

  • Dow Pokes Higher; Microsoft Drops 9% Friday, 24 Jul 2009 | 2:56 PM ET

    Stocks took a hit Friday as a drop in consumer sentiment exacerbated losses triggered by a disappointing round of earnings from Microsoft, Amazon and AmEx. But the Dow poked higher in afternoon trading Microsoft shares fell nearly 10%.

  • Stocks Slide as Earnings, Sentiment Disappoint Friday, 24 Jul 2009 | 12:37 PM ET

    Stocks skidded Friday as a drop in consumer sentiment exacerbated losses triggered by a disappointing round of earnings from American Express, Amazon and Microsoft.

  • Recovery Canaries in the Economic Coal Mine Thursday, 23 Jul 2009 | 11:54 AM ET
    earnings_central_badge.jpg

    Hailing from four separate corners of the U.S. economy, Apple, Caterpillar, Starbucks, and Merck all beat the street. Throw in the banks and now you’re talking five corners. It’s bullish — 90 percent of the American workforce and rising business may be doing some spending and risk-taking after all. I like this story a lot.

  • Wyeth Beats Street Target, Ups Guidance Thursday, 23 Jul 2009 | 11:10 AM ET
    Wyeth Earnings

    Drug maker Wyeth, in the process of being acquired by Pfizer, reported a quarterly profit that was better than analysts predicted and also raised its full-year earnings guidance.

  • Thursday Look Ahead: Busiest Day for Earnings on Tap Wednesday, 22 Jul 2009 | 9:03 PM ET

    The busiest day yet for second quarter earnings reports could put some juice back into the stock market Thursday.

  • Dow Skids; Nasdaq Gains for 11th Day Wednesday, 22 Jul 2009 | 5:36 PM ET

    The Dow and S&P snapped their winning streaks Wednesday as disappointing earnings from two of Wall Street's biggest names overshadowed another round of earnings beats.

  • Apple Results Buoy Nasdaq; Banks Skid Wednesday, 22 Jul 2009 | 2:38 PM ET

    Stocks wobbled Wednesday as a slew of earnings beats, including one from Pfizer, were encouraging but disappointing reports from two of Wall Street's biggest names dragged on the market.

  • Stocks Bounce Around; Wells, Morgan Slide Wednesday, 22 Jul 2009 | 11:42 AM ET

    Stocks wobbled Wednesday as a slew of earnings beats, including one from Pfizer, were encouraging but disappointing reports from two of Wall Street's biggest names dragged on the market.

  • China On A Roll Wednesday, 22 Jul 2009 | 9:28 AM ET

    The Chinese get going, again: as the Shanghai Index has hit new 52-week highs, Chinese investors have rushed back into the market, opening the most new stock accounts (484,799 last week) in the past 18 months.

  • Pfizer's Profit Slightly Tops Forecasts Wednesday, 22 Jul 2009 | 9:16 AM ET

    Pfizer's second-quarter profit slightly exceeded analysts' estimates Wednesday and the company said it has achieved "significant milestones" regarding the pending Wyeth acquisition.

  • Futures Fall More on Wells, Morgan Letdown Wednesday, 22 Jul 2009 | 8:16 AM ET

    Futures indicated a lower open for Wall Street Wednesday as cautious words from Federal Reserve Chairman Ben Bernanke and Yahoo's missing revenue expectations lent to investors taking profits.

  • 11 Earnings Reports to Watch this Week Tuesday, 21 Jul 2009 | 9:26 AM ET

    Last night on CNBC Reports, I ran a stock screen on 150 companies scheduled to report earnings between today and Friday.  Here are the 11 companies that came up and deserve a deeper look.

  • Art Cashin: My Take on Goldman's S&P Call Monday, 20 Jul 2009 | 3:04 PM ET

    Goldman Sachs issued a bullish note on the S&P 500, raising its target for the index to 1060 from 940 by year's end. Art Cashin, director of floor operations at UBS Financial Services, offered CNBC his take on the Goldman note and the stock markets.

  • My ICAD Infraction: One Year Later Wednesday, 15 Jul 2009 | 3:28 PM ET

    Man, time flies. I can't believe almost a year has passed since the incident at ICAD. That's the big Alzheimer's Disease scientific research conference that was held in Chicago in late July last year. This year, it's in Vienna and it's going on right now.

  • Could Pharma Surprise To The Upside? Tuesday, 14 Jul 2009 | 5:42 PM ET

    Investors are placing their bets ahead of a string of pharma earnings due both this week and next. What must you know?

  • Weak Dollar May Help Large Cap Earnings Monday, 13 Jul 2009 | 9:12 AM ET

    As investors brace for a rollercoaster ride during the second-quarter earnings season, the dollar's weakness in the last three months could have played a key role for some multinational companies. 

  • Sell Block: Insana Too Bullish? Thursday, 9 Jul 2009 | 7:43 PM ET

    The Wall Street vet has high hopes for housing, but Cramer isn’t so sure about the call.